AmplifyBio: AmplifyBio and Xcell enter TCR T-cell therapy manufacturing deal
AmplifyBio and Xcell Biosciences have announced a strategic collaboration to manufacture engineered T-cell receptor (TCR) therapies.
Read full article »
AmplifyBio is an Ohio-based preclinical CRO that offers services such as method development and bioanalytics for industries including pharmaceuticals and biotechnology.
Read more